| Primary |
| Schizophrenia |
45.9% |
| Psychotic Disorder |
10.9% |
| Schizophrenia, Paranoid Type |
7.7% |
| Depression |
5.7% |
| Schizoaffective Disorder |
4.6% |
| Anxiety |
4.5% |
| Hypertension |
2.6% |
| Bipolar Disorder |
2.5% |
| Epilepsy |
2.0% |
| Mental Disorder |
2.0% |
| Parkinson's Disease |
2.0% |
| Insomnia |
1.5% |
| Dementia |
1.4% |
| Schizophrenia, Disorganised Type |
1.2% |
| Constipation |
1.0% |
| Hallucination |
1.0% |
| Bipolar I Disorder |
0.9% |
| Major Depression |
0.9% |
| Agitation |
0.8% |
| Atrial Fibrillation |
0.8% |
|
| White Blood Cell Count Decreased |
14.3% |
| White Blood Cell Count Increased |
12.9% |
| Pyrexia |
8.2% |
| Somnolence |
8.2% |
| Weight Increased |
7.3% |
| Vomiting |
5.7% |
| Urinary Tract Infection |
5.0% |
| Tachycardia |
4.1% |
| Weight Decreased |
4.1% |
| Surgery |
3.9% |
| Tremor |
3.4% |
| Death |
3.2% |
| Neutropenia |
2.9% |
| Transaminases Increased |
2.7% |
| Obsessive-compulsive Disorder |
2.5% |
| Psychotic Disorder |
2.5% |
| Speech Disorder |
2.5% |
| Suicide Attempt |
2.5% |
| Vertigo |
2.3% |
| Electrocardiogram Qt Prolonged |
2.0% |
|
| Secondary |
| Schizophrenia |
23.7% |
| Product Used For Unknown Indication |
14.9% |
| Drug Use For Unknown Indication |
14.7% |
| Schizophrenia, Paranoid Type |
7.4% |
| Psychotic Disorder |
6.7% |
| Schizophrenia, Undifferentiated Type |
4.1% |
| Depression |
3.3% |
| Ill-defined Disorder |
3.0% |
| Parkinson's Disease |
2.6% |
| Anxiety |
2.6% |
| Schizoaffective Disorder |
2.5% |
| Bipolar Disorder |
2.3% |
| Epilepsy |
2.2% |
| Hypertension |
1.9% |
| Mental Disorder |
1.6% |
| Insomnia |
1.5% |
| Contraception |
1.4% |
| Laxative Supportive Care |
1.4% |
| Hallucination |
1.0% |
| Pain |
1.0% |
|
| White Blood Cell Count Decreased |
12.5% |
| Weight Increased |
11.3% |
| White Blood Cell Count Increased |
9.2% |
| Vertigo |
6.5% |
| Psychiatric Symptom |
6.0% |
| Somnolence |
5.9% |
| Sinus Tachycardia |
5.1% |
| Tremor |
5.0% |
| Pyrexia |
4.2% |
| Vomiting |
4.1% |
| Upper Respiratory Tract Infection |
3.9% |
| Weight Decreased |
3.8% |
| Tachycardia |
3.2% |
| Myopathy |
3.0% |
| Supraventricular Tachycardia |
3.0% |
| Sudden Death |
2.9% |
| Urinary Tract Infection |
2.9% |
| Neutropenia |
2.7% |
| Psychotic Disorder |
2.4% |
| Schizophrenia |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.5% |
| Drug Use For Unknown Indication |
16.6% |
| Schizophrenia |
14.1% |
| Parkinson's Disease |
9.5% |
| Psychotic Disorder |
7.3% |
| Anorexia Nervosa |
5.3% |
| Schizophrenia, Paranoid Type |
4.2% |
| Depression |
3.2% |
| Bipolar Disorder |
2.7% |
| Bipolar I Disorder |
2.7% |
| Major Depression |
2.0% |
| Obsessive-compulsive Personality Disorder |
2.0% |
| Epilepsy |
1.8% |
| Abnormal Behaviour |
1.5% |
| Affective Disorder |
1.3% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Deep Vein Thrombosis |
1.3% |
| Schizoaffective Disorder |
1.3% |
| Colitis Ulcerative |
1.2% |
| Crohn's Disease |
1.2% |
|
| Supraventricular Extrasystoles |
23.4% |
| Weight Increased |
16.1% |
| Eyelid Oedema |
5.1% |
| Overdose |
5.1% |
| Parkinsonism |
4.4% |
| Psychotic Disorder |
4.4% |
| Somnolence |
4.4% |
| Transaminases Increased |
4.4% |
| Nervous System Disorder |
3.6% |
| Hepatitis Acute |
2.9% |
| Intentional Self-injury |
2.9% |
| Leukopenia |
2.9% |
| Neutropenia |
2.9% |
| Overweight |
2.9% |
| Platelet Count Decreased |
2.9% |
| Visual Impairment |
2.9% |
| Bronchitis |
2.2% |
| Death |
2.2% |
| Drug Dose Omission |
2.2% |
| Hepatitis |
2.2% |
|
| Interacting |
| Schizophrenia |
23.5% |
| Drug Use For Unknown Indication |
20.2% |
| Hallucination |
8.1% |
| Insomnia |
7.7% |
| Delirium |
6.5% |
| Anxiety |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Schizophrenia, Paranoid Type |
4.5% |
| Mania |
3.6% |
| Psychotic Disorder |
2.8% |
| Depression |
2.0% |
| Hallucination, Visual |
2.0% |
| Schizoaffective Disorder |
1.6% |
| Abnormal Behaviour |
1.2% |
| Agitation |
1.2% |
| Myocardial Infarction |
1.2% |
| Parkinson's Disease |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Aggression |
0.8% |
| Arrhythmia |
0.8% |
|
| Drug Interaction |
25.4% |
| Polydipsia |
12.7% |
| Withdrawal Syndrome |
11.3% |
| Tachycardia |
8.5% |
| Somnolence |
5.6% |
| Akathisia |
4.2% |
| Liver Function Test Abnormal |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Hepatitis Acute |
2.8% |
| Psychotic Disorder |
2.8% |
| Shock |
2.8% |
| Suicide Attempt |
2.8% |
| Ventricular Extrasystoles |
2.8% |
| Electrocardiogram Qt Prolonged |
1.4% |
| Hepatic Enzyme Increased |
1.4% |
| Hypotension |
1.4% |
| Orthostatic Hypotension |
1.4% |
| Pancytopenia |
1.4% |
| Pharyngeal Oedema |
1.4% |
| Poisoning |
1.4% |
|
